<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[EPL | Certified Safe]]></title><description><![CDATA[EPL | Certified Safe]]></description><link>https://www.equineperformancelabs.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Fri, 17 Apr 2026 23:55:24 GMT</lastBuildDate><atom:link href="https://www.equineperformancelabs.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[The Biologic Breakdown: In Vitro Characterization of Equine UC Allograft]]></title><description><![CDATA[To characterize the protein composition and cytokine profile of a cryopreserved, microparticulate equine umbilical cord (UC) allograft using mass spectrometry (MS) and enzyme-linked immunosorbent assay (ELISA).  Methods Sample Preparation  UC tissue was harvested from 11 single-source, healthy equine donors. Cryopreserved at −80 °C and processed into microparticulate suspension. A total of 13 samples were analyzed.  Proteomic Analysis:  High-resolution tandem mass spectrometry (Orbitrap...]]></description><link>https://www.equineperformancelabs.com/post/the-biologic-breakdown-in-vitro-characterization-of-equine-uc-allograft</link><guid isPermaLink="false">69de71ccb9feb7db43b9d633</guid><category><![CDATA[For Veterinarians]]></category><pubDate>Tue, 14 Apr 2026 16:59:01 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/c02a88_83daca63c2fc4e10adea007bf1780798~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Rachel Rodrigue</dc:creator></item><item><title><![CDATA[Paving the Way: Defining Safety, Consistency &#38; Clinical Readiness in Equine Biologics]]></title><description><![CDATA[The following is a summary of the Article “Cryopreserved equine umbilical cord tissue allograft characterization and biocompatibility in vivo in musculoskeletal tissues: a controlled study” that was originally published in BMC Medicine, 2025 authored by Bertone et al. 1  Background:  Musculoskeletal (MSK) injuries are prevalent in equine and human athletes. Biologic tissue allografts, particularly from the umbilical cord (UC), offer potential for MSK tissue repair. However, characterization...]]></description><link>https://www.equineperformancelabs.com/post/copy-of-peer-reviewed-42-day-in-vivo-safety-and-characterization</link><guid isPermaLink="false">69c370d1dbf1d5b601306203</guid><category><![CDATA[For Veterinarians]]></category><pubDate>Tue, 13 Jan 2026 06:21:42 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/c02a88_cb95b40dbdb64e13b208a0ca6f9478fd~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Rachel Rodrigue</dc:creator></item><item><title><![CDATA[The Safety Standard: Evaluating Cryopreserved Equine UC Allografts]]></title><description><![CDATA[This summary highlights the robust safety profile of a cryopreserved equine umbilical cord allograft, as demonstrated through three comprehensive in vivo studies published in “Cryopreserved equine umbilical cord tissue allograft characterization and biocompatibility in vivo in musculoskeletal tissues: a controlled study.” BMC Medicine, 2025.1  Study Overview Three in vivo studies evaluated safety and biocompatibility of cryopreserved equine umbilical cord (UC) allograft.  Focus on...]]></description><link>https://www.equineperformancelabs.com/post/copy-of-peer-reviewed-42-day-in-vivo-safety-and-characterization-1</link><guid isPermaLink="false">69c370f8149f4fed5650ecd1</guid><category><![CDATA[For Veterinarians]]></category><pubDate>Wed, 01 Oct 2025 05:22:22 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/c02a88_7c94f0782ab34d08a24c6d5dc1bdf706~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Rachel Rodrigue</dc:creator></item><item><title><![CDATA[The Consistency Code: Evaluating Protein &#38; Cytokine Uniformity in Equine UC Allografts]]></title><description><![CDATA[This summary document highlights the lot-to-lot consistency of a cryopreserved equine umbilical cord (UC) allograft; equicenta™ CTM, as demonstrated through proteomic and cytokine analyses across multiple donors and batches. These results were first published in Bertone AL et al. “Cryopreserved equine umbilical cord tissue allograft characterization and biocompatibility in vivo in musculoskeletal tissues: a controlled study.” BMC Medicine, 2025 Study Overview Objective:  To evaluate the...]]></description><link>https://www.equineperformancelabs.com/post/peer-reviewed-42-day-in-vivo-safety-and-characterization</link><guid isPermaLink="false">69c36f778f0e652aaa30866c</guid><category><![CDATA[For Veterinarians]]></category><pubDate>Fri, 08 Aug 2025 05:20:39 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/c02a88_324b38d3653a43d4a75495b169c82a10~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Rachel Rodrigue</dc:creator></item></channel></rss>